Amylyx Pharmaceuticals Etf Price History

AMLX Etf  USD 5.66  0.39  7.40%   
If you're considering investing in Amylyx Etf, it is important to understand the factors that can impact its price. As of today, the current price of Amylyx Pharmaceuticals stands at 5.66, as last reported on the 26th of November, with the highest price reaching 5.81 and the lowest price hitting 5.36 during the day. Amylyx Pharmaceuticals is slightly risky given 3 months investment horizon. Amylyx Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.31, which signifies that the etf had a 0.31% return per unit of risk over the last 3 months. We were able to break down and interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.75% are justified by taking the suggested risk. Use Amylyx Pharmaceuticals Risk Adjusted Performance of 0.211, mean deviation of 4.24, and Downside Deviation of 4.91 to evaluate company specific risk that cannot be diversified away.
  
Amylyx Etf price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.3083

Best PortfolioBest Equity
Good Returns
Average ReturnsAMLX
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.67
  actual daily
50
50% of assets are less volatile

Expected Return

 1.75
  actual daily
34
66% of assets have higher returns

Risk-Adjusted Return

 0.31
  actual daily
24
76% of assets perform better
Based on monthly moving average Amylyx Pharmaceuticals is performing at about 24% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amylyx Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book
1.8412
Enterprise Value Ebitda
(11.71)
Price Sales
1.8385
Shares Float
42.2 M
Wall Street Target Price
7.5

Amylyx Pharmaceuticals Etf Price History Chart

There are several ways to analyze Amylyx Pharmaceuticals Etf price data. The simplest method is using a basic Amylyx candlestick price chart, which shows Amylyx Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 11, 20247.03
Lowest PriceSeptember 4, 20242.09

Amylyx Pharmaceuticals November 26, 2024 Etf Price Synopsis

Various analyses of Amylyx Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Amylyx Etf. It can be used to describe the percentage change in the price of Amylyx Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Amylyx Etf.
Amylyx Pharmaceuticals Price Daily Balance Of Power 0.87 
Amylyx Pharmaceuticals Price Rate Of Daily Change 1.07 
Amylyx Pharmaceuticals Price Action Indicator 0.27 
Amylyx Pharmaceuticals Accumulation Distribution 77,580 

Amylyx Pharmaceuticals November 26, 2024 Etf Price Analysis

When benchmark price declines in a down market, there may be an uptick in Amylyx Pharmaceuticals Etf price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Amylyx Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Amylyx Pharmaceuticals Etf and then apply it to test your longer-term investment strategies against Amylyx.

Amylyx Etf Price History Data

The price series of Amylyx Pharmaceuticals for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 4.94 with a coefficient of variation of 36.2. The prices are distributed with arithmetic mean of 3.88. The median price for the last 90 days is 3.39. The company issued dividends on March 28, 2018.
OpenHighLowCloseVolume
11/25/2024 5.42  5.81  5.36  5.66  1,001,641 
11/22/2024 5.33  5.40  5.15  5.27  834,888 
11/21/2024 5.23  5.42  4.98  5.19  1,889,113 
11/20/2024 5.22  5.39  5.09  5.23  934,367 
11/19/2024 5.20  5.60  5.09  5.22  2,073,090 
11/18/2024 5.23  5.88  5.14  5.30  2,867,667 
11/15/2024 4.98  5.07  4.57  4.76  1,579,925 
11/14/2024 5.32  5.51  4.89  5.02  2,752,764 
11/13/2024 6.25  6.45  5.64  5.68  1,645,513 
11/12/2024 6.83  6.95  6.11  6.24  2,003,441 
11/11/2024 6.89  7.08  6.48  7.03  2,000,629 
11/08/2024 6.80  7.27  6.38  6.70  1,955,604 
11/07/2024 6.00  7.09  5.95  6.54  1,728,250 
11/06/2024 5.83  6.29  5.72  6.22  1,510,528 
11/05/2024 5.67  5.83  5.53  5.81  790,328 
11/04/2024 5.58  5.80  5.50  5.70  841,113 
11/01/2024 5.42  5.80  5.41  5.64  1,310,411 
10/31/2024 5.21  5.54  5.20  5.40  1,113,725 
10/30/2024 5.06  5.48  5.06  5.27  1,267,974 
10/29/2024 5.42  5.45  4.88  5.07  1,558,223 
10/28/2024 5.33  5.66  5.14  5.33  1,899,786 
10/25/2024 4.90  5.50  4.86  5.31  2,128,067 
10/24/2024 5.00  5.14  4.80  4.90  1,107,468 
10/23/2024 5.05  5.30  4.71  4.96  2,955,333 
10/22/2024 4.66  4.83  4.45  4.53  1,169,957 
10/21/2024 4.77  5.04  4.40  4.66  2,563,388 
10/18/2024 4.07  5.44  3.86  4.78  4,822,316 
10/17/2024 4.13  4.46  3.36  3.92  3,317,028 
10/16/2024 3.98  4.14  3.86  4.08  1,338,559 
10/15/2024 3.60  3.95  3.60  3.94  1,541,571 
10/14/2024 3.55  3.64  3.42  3.58  709,394 
10/11/2024 3.47  3.63  3.44  3.55  1,068,152 
10/10/2024 3.36  3.47  3.28  3.46  874,354 
10/09/2024 3.27  3.48  3.20  3.39  1,524,869 
10/08/2024 3.08  3.33  3.07  3.26  1,248,332 
10/07/2024 3.11  3.18  3.04  3.08  830,032 
10/04/2024 2.94  3.16  2.94  3.12  742,686 
10/03/2024 3.01  3.07  2.91  2.94  788,751 
10/02/2024 3.05  3.07  2.93  3.03  738,408 
10/01/2024 3.25  3.29  3.05  3.06  1,134,348 
09/30/2024 3.05  3.27  3.05  3.24  1,487,123 
09/27/2024 3.25  3.28  3.05  3.08  764,671 
09/26/2024 3.13  3.23  3.09  3.20  872,913 
09/25/2024 3.00  3.16  2.95  3.12  1,761,377 
09/24/2024 2.95  3.04  2.87  3.01  1,283,388 
09/23/2024 3.23  3.34  2.88  2.91  2,405,008 
09/20/2024 2.90  3.28  2.86  3.10  4,071,873 
09/19/2024 2.97  2.97  2.88  2.88  1,280,403 
09/18/2024 2.90  2.97  2.82  2.88  1,478,705 
09/17/2024 2.82  2.97  2.79  2.92  1,671,064 
09/16/2024 2.64  2.68  2.59  2.65  733,984 
09/13/2024 2.48  2.69  2.48  2.62  843,130 
09/12/2024 2.56  2.64  2.47  2.49  891,915 
09/11/2024 2.63  2.66  2.37  2.57  1,696,540 
09/10/2024 2.57  2.70  2.54  2.66  1,642,220 
09/09/2024 2.34  2.54  2.28  2.52  1,314,126 
09/06/2024 2.30  2.48  2.30  2.37  1,553,744 
09/05/2024 2.11  2.22  2.09  2.20  496,300 
09/04/2024 2.15  2.17  2.08  2.09  464,105 
09/03/2024 2.23  2.24  2.13  2.16  582,330 
08/30/2024 2.11  2.23  2.09  2.22  414,190 

About Amylyx Pharmaceuticals Etf history

Amylyx Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amylyx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amylyx Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amylyx Pharmaceuticals stock prices may prove useful in developing a viable investing in Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.

Amylyx Pharmaceuticals Quarterly Net Working Capital

256.64 Million

Amylyx Pharmaceuticals Etf Technical Analysis

Amylyx Pharmaceuticals technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of Amylyx Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Amylyx Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

Amylyx Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Amylyx Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Amylyx Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amylyx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Other Information on Investing in Amylyx Etf

Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.